Prognostic significance of ASXL1, JAK2V617F mutations and JAK2V617F allele burden in Philadelphia-negative myeloproliferative neoplasms.

Saved in:

Bibliographic Details
Title:	Prognostic significance of ASXL1, JAK2V617F mutations and JAK2V617F allele burden in Philadelphia-negative myeloproliferative neoplasms.
Authors:	Yonal-Hindilerden I; Division of Hematology, Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Fatih-Istanbul, Turkey., Daglar-Aday A; Division of Hematology, Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Fatih-Istanbul, Turkey., Akadam-Teker B; Division of Hematology, Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Fatih-Istanbul, Turkey., Yilmaz C; Division of Hematology, Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Fatih-Istanbul, Turkey., Nalcaci M; Division of Hematology, Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Fatih-Istanbul, Turkey., Yavuz AS; Division of Hematology, Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Fatih-Istanbul, Turkey., Sargin D; Division of Hematology, Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Fatih-Istanbul, Turkey.
Source:	Journal of blood medicine [J Blood Med] 2015 Jun 01; Vol. 6, pp. 157-75. Date of Electronic Publication: 2015 Jun 01 (Print Publication: 2015).
Publication Type:	Journal Article
Journal Info:	Publisher: Dove Medical Press Country of Publication: New Zealand NLM ID: 101550884 Publication Model: eCollection Cited Medium: Print ISSN: 1179-2736 (Print) Linking ISSN: 11792736 NLM ISO Abbreviation: J Blood Med Subsets: PubMed not MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1179-2736
DOI:	10.2147/JBM.S78826